AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

PREVALENCE OF SCAPULAR DYSKINESIS

Recruitingn/aAges 27 Years - 40 YearsAllCairo University
💬

In plain words

What the trial is, and whether it could suit you

Objective: This study will aim to determine the prevalence of scapular dyskinesis (SD) among Egyptian physical therapy practitioners and will explore associated epidemiological factors, including age, sex, BMI, shoulder and neck symptoms, and scapular stabilizer muscle strength. Design: A cross-sectional observational study will be conducted, including 121 licensed Egyptian physical therapists aged 27 to 40 years. Participants will be divided into three age-based groups. Methods: Each participant will undergo a clinical examination for SD using the Scapular Dyskinesis Test (SDT) and the Lateral Scapular Slide Test (LSST). Pain intensity will be assessed using the Visual Analog Scale (VAS), and musculoskeletal symptoms will be recorded using the Nordic Musculoskeletal Questionnaire (NMQ). Shoulder range of motion and the strength of scapular stabilizer muscles (serratus anterior, mid

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: Licensed physical therapy practitioners actively working in clinical settings (Soliño et al., 2024). Age between 27 and 40 years (Jeong \& Kim, 2023). Minimum of one year of clinical experience or exposure to physical activity (Jeong \& Kim, 2023). No current shoulder pain or symptoms at the time of assessment (Soliño et al., 2024). Willingness to participate and provide informed consent. Exclusion Criteria: Acute shoulder or neck injury within the last month (Jeong \& Kim, 2023). History of upper body orthopedic surgery (Jeong \& Kim, 2023). Known neurological or musculoskeletal disorders affecting shoulder mechanics (Burn et al., 2016). Participation in overhead or collision sports with high scapular loading (Burn et al., 2016). Inability to complete assessment procedures due to physical limitations (Soliño et al., 2024).
💊

What it tests

  • Not listed
📍

Where

1 site
Faculty of Physical Therapy
Cairo, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy